Effects of exogenous LH administration during ovarian stimulation of pituitary down-regulated young oocyte donors on oocyte yield and developmental competence

Human Reproduction

Volumn 17, Issue 12, 2002, Pages 3129-3137

  Tesarik, Jan ^a   Mendoza, Carmen ^b  

^a Molecular Assisted Reproduction and Genetics   (Spain)

^b UNIVERSITY OF GRANADA   (Spain)

Author keywords

LH; Oocyte developmental competence; Oocyte donation; Ovarian stimulation; Pituitary down regulation

Indexed keywords

ACETYLSALICYLIC ACID; CHORIONIC GONADOTROPIN; CONTRACEPTIVE AGENT; ESTRADIOL VALERATE; ETHINYLESTRADIOL PLUS LYNESTRENOL; FOLLITROPIN; GONADORELIN AGONIST; HUMAN MENOPAUSAL GONADOTROPIN; LONG ACTING DRUG; LUTEINIZING HORMONE; NEOFERTINORM; NORETHISTERONE; NORETHISTERONE ACETATE; PROGESTERONE; RECOMBINANT FOLLITROPIN; STROGESTAN; TRIPTORELIN; DRUG DERIVATIVE; ESTRADIOL;

ADRENAL SUPPRESSION; ADULT; ARTICLE; CLINICAL PROTOCOL; CLINICAL TRIAL; COMPETENCE; COMPUTER SYSTEM; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DONOR; DOWN REGULATION; DRUG EFFICACY; FEMALE; FERTILIZATION; HEALTH PROGRAM; HORMONE ACTION; HUMAN; HUMAN CELL; HYPOPHYSIS; INFERTILITY; LUTEAL PHASE; LUTEINIZING HORMONE BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; METAPHASE; MORPHOLOGY; NIDATION; OOCYTE; OOCYTE DEVELOPMENT; OOCYTE DONATION; OOCYTE MATURATION; OVARY CYST; OVARY HYPERSTIMULATION; PROSPECTIVE STUDY; QUALITY CONTROL; RANDOMIZED CONTROLLED TRIAL; SUPPLEMENTATION; ZYGOTE; BLOOD; CELL COUNT; COMPARATIVE STUDY; EMBRYO; EMBRYO TRANSFER; HISTOLOGY; INTRACYTOPLASMIC SPERM INJECTION; MIDDLE AGED; OVULATION INDUCTION; PREGNANCY;

FALLOPIA;

ADULT; ASPIRIN; CELL COUNT; EMBRYO; EMBRYO IMPLANTATION; EMBRYO TRANSFER; ESTRADIOL; FEMALE; FOLLICLE STIMULATING HORMONE; HUMANS; LUTEINIZING HORMONE; MALE; MIDDLE AGED; OOCYTE DONATION; OOCYTES; OVULATION INDUCTION; PREGNANCY; SPERM INJECTIONS, INTRACYTOPLASMIC; ZYGOTE;

EID: 0036904273     PISSN: 02681161     EISSN: None     Source Type: Journal    
DOI: 10.1093/humrep/17.12.3129     Document Type: Article

References (27)

1. Balasch, J., Fa'bregues, F., Creus, M., Moreno, V., Puerto, B., Penarrubia, I., Carmona, F. Vanrell, J.A. (1996) Pure and highly purified follicle-stimulating hormone alone or in combination with human menopausal gonadotrophin for ovarian stimulation after pituitary suppression in in-vitro fertilization. Hum. Reprod., 11, 2400-2404.
2. Balasch, J., Vidal, E., Penarrubia, J., Casamitjana, R., Carmona, F., Creus, M., Fa'bregues, F. Vanrell, J.A. (2001) Suppression of LH during ovarian stimulation: Analysing threshold values and effects on ovarian response and the outcome of assisted reproduction in down-regulated women stimulated with recombinant FSH. Hum. Reprod. 16, 1636-1643.
3. Bolton, V.N., Hawes, S.M., Taylor, C.T. and Parsons, J.H. (1989) Development of spare human preimplantation embryos in vitro: an analysis of the correlations among gross morphology, cleavage rates and development to the blastocyst. J. In Vitro Fert. Embryo Transfer, 6, 30-35.
4. De Placido, G., Mollo, A., Alviggi, C., Strina, I., Varricchio, M.T., Ranieri, A., Colacurci, N., Tolino, A. and Wilding, M. (2001) Rescue of IVF cycles by HMG in pituitary down-regulated normogonadotrophic young women characterized by a poor initial response to recombinant FSH. Hum. Reprod. 16, 1875-1879.
5. Filicori, M. (1999) The role of luteinizing hormone in folliculogenesis and ovulation induction. Fertil. Steril., 71, 405-414.
6. Filicori, M., Cognigni, G.G., Taraborrelli, S., Spettoli, D., Ciampaglia, W., De Fatis, C.T. and Pocognoli, P. (1999) Luteinizing hormone activity supplementation enhances follicle-stimulating hormone efficacy and improves ovulation induction outcome. J. Clin. Endocrinol. Metab., 84, 2659-2663.
7. Filicori, M., Cognigni, G.E., Taraborrelli, S., Spettoli, D., Ciampaglia, W., De Fatis, C.T., Pocognoli, P., Cantelli, B. and Boschi, S. (2001) Luteinizing hormone activity in menotropins optimizes folliculogenesis and treatment in controlled ovarian stimulation. J. Clin. Endocrinol. Metab., 86, 337-343.
8. Fleming, R., Chung, C.C., Yates, R.W.S. and Coutts, J.R.T. (1996) Purified urinary follicle stimulating hormone induces different hormone profiles compared to menotrophins, dependent upon the route of administration and endogenous luteinizing hormone activity. Hum. Reprod., 11, 1854-1858.
9. Fleming, R., Rehka, P., Deshpande, N., Jamieson, M.E., Yates, R.W.S. and Lyall, H. (2000) Suppression of LH during ovarian stimulation: Effects differ in cycles stimulated with purified urinary FSH and recombinant FSH. Hum. Reprod., 15, 1440-1445.
10. Hillier, S.G. (1994) Current concepts of the roles of follicle stimulating hormone and luteinizing hormone in folliculogenesis. Hum. Reprod., 9, 188-191.
11. Hughes, E.G., Fedorkow, D.M., Daya, S., Sagle, M.A., Van de Koppel, P. and Collins, J.A. (1992) The routine use of gonadotropin-releasing hormone agonists prior to in vitro fertilization and gamete intrafallopian transfer: A meta-analysis of randomized controlled trials. Fertil. Steril., 58, 888-896.
12. Meo, F., Ranieri, D.M., KHadum, I. and Serhal, P. (2002) Ovarian response and in vitro fertilization outcome in patients with reduced ovarian reserve who were stimulated wtih recombinant follicle-stimulated hormone or human menopausal gonadotropin. Fertil. Steril., 77, 630-632.
13. Paulson, R.J., Saur, M.V. and Lobo, R.A. (1990) Embryo implantation after human in vitro fertilization: Importance of endometrial receptivity. Fertil. Steril., 53, 870-874.
14. Rao, C.V. (2001) Multiple novel roles of luteinizing hormone. Fertil. Steril., 76, 1097-1100.
15. Shemesh, M. (2001) Actions of gonadotrophins on the uterus. Reproduction, 121, 835-842.
16. Simon, C., Velasco, J.J.G., Valbuena, D., Peinado, J.A., Moreno, C., Remohi, J. and Pellicer, A. (1998) Increasing uterine receptivity by decreasing estradiol levels during the preimplantation period in high responders with the use of a follicle-stimulating hormone step-down regimen. Fertil. Steril., 70, 234-239.
17. Söderström-Antilla, V., Foudila, T. and Hovatta, O. (1996) A randomized comparative study of highly purified follicle stimulating hormone and human menopausal gonadotrophin for ovarian hyperstimulation in an oocyte donation programme. Hum. Reprod., 9, 1864-1870.
18. Tesarik, J. and Greco, E. (1999) The probability of abnormal preimplantation development can be predicted by a single static observation on pronuclear stage morphology. Hum. Reprod., 14, 1318-1323.
19. Tesarik, J. and Mendoza, C. (1995) Nongenomic effects of 17β-estradiol on maturing human oocytes: Relationship to oocyte developmental potential. J. Clin. Endocrinol. Metab., 80, 1438-1443.
20. Tesarik, J. and Mendoza, C. (1997) Direct non-genomic effects of follicular steroids on maturing human oocytes: Oestrogen versus androgen antagonism. Hum. Reprod. Update, 3, 95-100.
21. 2+ fluxes and oocyte cytoplasmic dislocation. Fertil. Steril., 64, 770-776.
22. Tesarik, J., Junca, A.M., Hazout, A., Aubriot, F.X., Nathan, C., Cohen-Bacrie, P. and Dumont-Hassan M. (2000) Embryos with high implantation potential after intracytoplasmic sperm injection can be recognized by a simple, non-invasive examination of pronuclear morphology. Hum. Reprod., 15, 1396-1399.
23. Tesarik, J., Mendoza, C. and Greco, E. (2002) Paternal effects acting during the first cell cycle of human preimplantation development after ICSI. Hum. Reprod., 17, 184-189.
24. Westergaard, L.G., Erb, K., Laursen, S.B., Rex, S. and Rasmussen, P.E. (1996) The effect of human menopausal gonadotrophin and highly purified, urine-derived follicle stimulating hormone on the outcome of in-vitro fertilization in down-regulated normogonadotrophic women. Hum. Reprod., 11, 1209-1213.
25. Westergaard, L.G., Laursen, S.B. and Yding Andersen, C. (2000) Increased risk of early pregnancy loss by profound suppression of luteinizing hormone during ovarian stimulation in normogonadotrophic women undergoing assisted reproduction. Hum. Reprod., 15, 1003-1008.
26. Westergaard, L.G., Erb, K., Laursen, S.B., Rex, S. and Rasmussen, P.E. (2001) Human menopausal gonadotrophin versus recombinant follicle-stimulating hormone in normogonadotropic women down-regulated with a gonadotropin-releasing hormone agonist who were undergoing in vitro fertilization and intracytoplasmic sperm injection: A prospective randomized study. Fertil. Steril., 76, 543-549.
27. World Health Organization. (1992) WHO Laboratory Manual for the Examination of Human Semen and Sperm-Cervical Mucus Interaction. 3rd edn. Cambridge University Press, Cambridge, UK. 1-107.